DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Taxonomy: IM- X-ray: Radiation dosimetry
BReP-SNAP-I-37 | Parametric Model Adjustment of Prescribed Mean Radiation Dose to Ensure Complete Coverage at Tumor Margins During Ablative 90Y Radioembolization S Kappadath1*, B Lopez1, A Braat2, R DiTusa1, A Mahvash1, B Toskich3, (1) University of Texas MD Anderson Cancer Center, Houston, TX, USA (2) University Medical Center, Utrecht, NL (3) Mayo Clinic, Jacksonville, FL, USA |
BReP-SNAP-I-38 | Patient Dose Estimates After Lactated Ringer's Related Breakthrough of a Rubidium-82 Generator N Busse1*, B Lofton2, J Stickel3, (1) Denver Health, Denver, CO, (2) Colorado Assn in Medical Phys (CAMP), Colorado Springs, CO, (3) Colorado Assn in Medical Phys (CAMP), Golden, CO |
PO-GeP-I-3 | A Body Mass Index-Based Method for Size-Specific Dose Estimates (SSDE) in Adults D Yan1,2*, B Chen2, W Lu1, J Qiu1, L Shi1, (1) Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, CN (2) Hwamei Hospital, university Of Chinese Academy Of Sciences, Ningbo, CN |
PO-GeP-I-31 | An Investigation of Using a Single CT Image to Assess Size-Specific Dose Estimates (SSDE) A Abuhaimed1*, C Martin2, (1) King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia, (2) University of Glasgow, Glasgow, UK |
PO-GeP-I-51 | Clinical Decision Making in CT: Risk Assessment Comparison Across 12 Risk Metrics in Patient Populations F Ria*, W Fu, J Hoye, P Segars, A Kapadia, E Samei, RAI Labs, Duke University Health System, Durham, NC |
PO-GeP-I-65 | Correlation of Body Mass Index (BMI) and Water Equivalent Diameter (Dw) Used for Size-Specific Dose Estimates (SSDE) A Abuhaimed1*, C Martin2, (1) King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia, (2) University of Glasgow, Glasgow, UK |
PO-GeP-I-74 | Dental and Maxillofacial Cone Beam Computed Tomography Dose Index in Full-Fan and Full-Scan Mode S Jia*, L Zhang, Y Xing, H Gao, Tsinghua University, Haidian Dist, 11CN, |
PO-GeP-I-99 | Effect of Contrast Agent Administration On Water Equivalent Diameter in CT B Viggiano*, T Szczykutowicz, University Wisconsin-Madison, Madison, WI |
PO-GeP-I-140 | Influence of Water Equivalent Diameter (Dw) Variability Inside the Scan Area On Size-Specific Dose Estimates (SSDE) A Abuhaimed1, C Martin2*, (1) King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia, (2) University of Glasgow, Glasgow, UK |
PO-GeP-I-183 | Radiation Risk Assessment of Using Gold Nanoparticles as Contrast Agent in Image-Guided Radiotherapy: A Monte Carlo Study J Chow1*, D Mututantri-bastiyange2, (1) Princess Margaret Cancer Centre, Toronto, ON, CA, (2) Ryerson University, Toronto, ON, CA |
PO-GeP-I-188 | Research Progress On Radiation Dose Optimization in CT Examination of Children in China D Xing1, W Lu1, L Jing2*, W Lu1, (1) Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong Province, CN, (2) Taian Tumor Hospital, Taian, Shandong Province, CN |
PO-GeP-I-211 | The Relationship Between Beam Width,Scan Length, and Dosimeter Dimension in CT Equilibrium Dose Measurement V Weir1, J Zhang2*, (1) Baylor University Medical Center, Plano, TX, (2) University of Kentucky, Lexington, KY |
PO-GeP-M-4 | 90Y-Microspheres Radioembolization for Selective Internal Radiation Therapy in NGHA, Saudi Arabia , Statistics and Dosimetry N SENHOU*, S Alshehri, National Guard Health Affairs, Riyadh, 01SA, |
PO-GeP-M-238 | How Low Can You Go? A CBCT Dose Reduction Study A Olch1*, P Alaei2, (1) University of Southern California, and Children's Hospital of Los Angeles, Los Angeles, CA, (2) University of Minnesota, Minneapolis, MN, AF |
PO-GeP-M-438 | The Effect of Dose Calculation Accuracy for HU to Electron Density Calibration For Iterative CBCT Reconstruction J Zavala Bojorquez1*, E Flores-Martinez2, T Atwood1, C Bojechko1, (1) University of California San Diego, La Jolla, CA, (2) University of Chicago Hospitals, Chicago, IL |
PO-GeP-T-394 | Evaluation of a Commercial Tungsten Eye Shield for Orthovoltage Beams Using Gafchromic Film M Shafiq ul Hassan1, H Chen1*, J Bond1, D Allen1, Z Chen1, (1) Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA |
PO-GeP-T-458 | Feasibility Study Using Low-Energy X-Ray to Treat Superficial Lesions for Head Cases S Hoffman*, H Kang, S Gros, R Patel, Loyola Univ Medical Center, Oak Park, IL |
PO-GeP-T-769 | The Effect of Single-Walled Carbon Nanotubes Over the Efficiency of the Protective Garment Against Diagnostic X-Ray R Zohdiaghdam1, M Mahmoudian2, N Riyahi-Alam3*, s salimi4, (1) Urmia University of Medical Sciences, ,,IR, (2) Nanotechnology Research Institute, Urmia University, Urmia, Iran, ,,IR, (3) Department of Medical Physics & Biomedical Engineering, School if Medicine, Tehran University of Medical Sciences(TUMS), Tehran, Iran, Tehran, ,IR, (4) Urmia University of Medical Sciences, Urmia, Iran, ,,IR |
SU-C-TRACK 1-2 | A Practical Model for Equilibrium Dose Measurement K Grizzard*, D Vergara, J Moroz, M Hoerner, Yale New Haven Hospital and Yale University School of Medicine, Department of Radiology and Biomedical Imaging, New Haven, CT |
SU-C-TRACK 1-6 | Implementation of Tube Current Modulation Into An Organ Dose Calculator for CT Patients C Lee1*, Y Yeom2, J Atkinson3, L Folio4, (1) National Cancer Institute, Rockville, MD, (2) National Cancer Institute, Rockville, MD, (3) Georgia Institute of Technology, Atlanta, GA,(4) National Institutes of Health, Bethesda, MD |
WE-D-TRACK 1-3 | 18F-FDG Labelling in Cell-Tracking PET Studies: Calculation of the Precise Absorbed Dose Deposited to Cell Nucleus and Correlation to in Vitro Biological Effects M Jacquemin1*, C Truillet2, D Broggio1, D Franck1, JM Bertho3, A Desbree1, (1) Institut for Radioprotection and Nuclear Safety, Paris, FR, (2) Alternative Energies and Atomic Energy Commission, Orsay, FR, (3) French Nuclear Safety, Montrouge, FR |
WE-F-TRACK 4-0 | Diagnostic Imaging and 100 MSv+ Doses W Sensakovic1*, M Rehani2*, M Lipford3*, T Szczykutowicz4*, (1) Mayo Clinic, Phoenix, AZ, (2) Massachusetts General Hospital, Boston, MA, (3) University of Wisconsin, Madison, WI, (4) University Wisconsin-Madison, Madison, WI |
WE-F-TRACK 4-1 | Do patient receive 100mSv+ from diagnostic scanning? W Sensakovic1*, M Rehani2*, M Lipford3*, T Szczykutowicz4*, (1) Mayo Clinic, Phoenix, AZ, (2) Massachusetts General Hospital, Boston, MA, (3) University of Wisconsin, Madison, WI, (4) University Wisconsin-Madison, Madison, WI |
WE-F-TRACK 4-2 | Patients with over 100 mSv doses: Experience from large scale studies to assess the magnitude W Sensakovic1*, M Rehani2*, M Lipford3*, T Szczykutowicz4*, (1) Mayo Clinic, Phoenix, AZ, (2) Massachusetts General Hospital, Boston, MA, (3) University of Wisconsin, Madison, WI, (4) University Wisconsin-Madison, Madison, WI |
WE-F-TRACK 4-3 | Dose Reduction Opportunities in MDCT W Sensakovic1*, M Rehani2*, M Lipford3*, T Szczykutowicz4*, (1) Mayo Clinic, Phoenix, AZ, (2) Massachusetts General Hospital, Boston, MA, (3) University of Wisconsin, Madison, WI, (4) University Wisconsin-Madison, Madison, WI |
WE-F-TRACK 4-4 | Round-Table Discussion W Sensakovic1*, M Rehani2*, M Lipford3*, T Szczykutowicz4*, (1) Mayo Clinic, Phoenix, AZ, (2) Massachusetts General Hospital, Boston, MA, (3) University of Wisconsin, Madison, WI, (4) University Wisconsin-Madison, Madison, WI |